Biohaven Ltd.
08/07/2026 | Press release | Distributed by Public on 08/07/2026 14:11
Management Change/Compensation (Form 8-K)
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On August 3, 2026, the Board of Directors (the "Board") of Biohaven Ltd. (the "Company") appointed John Yetimoglu as a director, effective August 6, 2026. Mr. Yetimoglu will serve in the class of directors whose term will expire at the Company's 2027 Annual Meeting of Shareholders. Mr. Yetimoglu has also been appointed as a member of the Nominating and Governance Committee of the Board.
There is no arrangement or understanding between Mr. Yetimoglu and any other person pursuant to which he was selected as a director of the Company, and there is no family relationship between Mr. Yetimoglu and any of the Company's other directors or executive officers. Since the beginning of the Company's last fiscal year, there are no transactions in which the Company was or is to be a participant and in which Mr. Yetimoglu or any member of his immediate family had or will have any interest that are required to be reported under Item 404(a) of Regulation S-K.
In accordance with the Company's compensation policy for non-employee directors, Mr. Yetimoglu is entitled to options to purchase the Company's common shares with an aggregate grant date fair value of $713,875. The shares underlying these options will vest 25% on grant and 25% on each of the following three anniversaries of grant, subject to Mr. Yetimoglu's continuous service through each vesting date. Additionally, Mr. Yetimoglu will be entitled to receive a $57,000 annual retainer for his service as a director and committee member.
2
Biohaven Ltd. published this content on August 07, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on August 07, 2026 at 20:11 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]